Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug.
about
Biosafe nanoscale pharmaceutical adjuvant materialsVersatile Room-Temperature-Phosphorescent Materials Prepared from N-Substituted Naphthalimides: Emission Enhancement and Chemical Conjugation.Cyclic-RGDyC functionalized liposomes for dual-targeting of tumor vasculature and cancer cells in glioblastoma: An in vitro boron neutron capture therapy studyControlled Detachment of Chemically Glued Cells.Small molecule-based ratiometric fluorescence probes for cations, anions, and biomoleculesThe self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.Fabrication of redox-responsive magnetic protein microcapsules from hen egg white by the sonochemical method.Non-invasive, real-time reporting drug release in vitro and in vivoA novel aggregation-induced emission enhancement triggered by the assembly of a chiral gelator: from non-emissive nanofibers to emissive micro-loops.Self-carried curcumin nanoparticles for in vitro and in vivo cancer therapy with real-time monitoring of drug releaseA novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cellsMultifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy.Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.RGD-mediated delivery of small-molecule drugs.Substituent Effects on Cytotoxic Activity, Spectroscopic Property, and DNA Binding Property of Naphthalimide Derivatives.Synthesis and Biological Evaluation of Novel Water-Soluble Poly-(ethylene glycol)-10-hydroxycamptothecin Conjugates.Photo-triggered fluorescent theranostic prodrugs as DNA alkylating agents for mechlorethamine release and spatiotemporal monitoring.NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real-Time in vivo Monitoring of Drug Release.Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.Targeted theranostic prodrugs based on an aggregation-induced emission (AIE) luminogen for real-time dual-drug tracking.Intracellular reduction/activation of a disulfide switch in thiosemicarbazone iron chelatorsPreparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.A fluorescence off-on reporter for real time monitoring of gemcitabine delivery to the cancer cells.Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.A naphthalimide based chemosensor for Zn2+, pyrophosphate and H2O2: sequential logic operations at the molecular level.Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release.Tumor Targeting with an isoDGR-Drug ConjugateChemical Modulation of in Vivo Macrophage Function with Subpopulation-Specific Fluorescent Prodrug Conjugates.Highly selective in vivo imaging of endogenous/exogenous phosphate ion over ATP and PPi.Stimuli-responsive multifunctional glyconanoparticle platforms for targeted drug delivery and cancer cell imagingFluorescein aldehyde with disulfide functionality as a fluorescence turn-on probe for cysteine and homocysteine in HEPES buffer.Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics.Rational Design of Cancer-Targeted Benzoselenadiazole by RGD Peptide Functionalization for Cancer Theranostics.A glutathione-activated phthalocyanine-based photosensitizer for photodynamic therapy.Monitoring of "on-demand" drug release using dual tumor marker mediated DNA-capped versatile mesoporous silica nanoparticles.Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.Photophysics, Electrochemistry, Morphology, and Bioimaging Applications of New 1,8-Naphthalimide Derivatives Containing Different Chromophores.A Redox-Activatable Fluorescent Sensor for the High-Throughput Quantification of Cytosolic Delivery of Macromolecules.Long-term thiol monitoring in living cells using bioorthogonal chemistry.Redox-responsive xanthene-coumarin-chlorambucil-based FRET-guided theranostics for "activatable" combination therapy with real-time monitoring.
P2860
Q26829798-4813CA53-C4B5-49D0-983C-CFECA26CF774Q30276413-A06EF163-37F2-45BC-B902-F33E64902FD6Q33829590-584044E6-6FDA-4B58-8059-48C03A148678Q33893829-C85521D1-580D-422E-9512-B40AF87491DBQ35287935-15FEC562-2A31-4D30-B91F-FF30137C151AQ35752126-ED348783-828B-4C0B-ADAA-FCC4FFF21C5DQ35753385-5EDBCC86-3619-4CE9-A56B-37E661BE2E78Q35800904-0823D82B-988C-4907-9D83-BD55305A8B21Q36223158-37A91F13-FE6D-4836-A291-5046C514B453Q36258999-44334DDB-3E78-4949-8168-F86A9EA4AFD1Q36738745-1410836F-0732-4088-AB90-D047141BA324Q37156311-85A767C4-7B76-4EEE-8FB8-9DD9BE7E4B61Q38539464-F1AFA0FC-5E90-4EE2-966D-19DF15137241Q38732486-452F37C9-41E9-43C5-9451-7858F11FAE36Q38813318-3759C3D7-6200-4A46-9B30-184ED9EE58F5Q38871223-FA7AFAF0-5D69-4D8C-932C-96AFC47DBDAFQ38872474-2C8D3719-64B0-42A9-A89F-F5F0E4AA6D54Q38890277-106CA8FA-C62C-4D06-9721-956FDA613361Q38898249-0372F6F9-F815-4FC9-8220-AE49AFF6A8A3Q38964655-163A3BCD-CB7C-4D71-B1C2-31F09C2A54D4Q38968208-AA858078-E81A-4F9C-A3DD-FCDEE97C8F20Q39077133-D4CF4507-3B88-45E2-8D18-CB116118358AQ39129321-8E35DA25-D650-4BDB-A306-702BE33C2CDDQ39187880-C941E417-8882-407B-B837-9BF1798B09B3Q39227118-35E0FFBC-E48D-4A0D-B100-0E484AED117AQ39848926-CF304CC7-1389-40ED-95D1-8C7C6294B031Q41019174-C3E62BAC-E0B3-4D03-ADE7-6061CC718298Q41849144-B3304C26-3E89-4A5C-B8CB-F2E3373E5A03Q41999361-26FBE743-5694-4C88-85B5-EAC8CF6AB7D3Q42263510-6E92799A-326C-4CA5-858E-776C86F3A603Q43529798-1A73E154-EE9B-45FC-8C1A-7F185BBF650BQ46277986-0DB2E2DC-03B2-4B08-95F4-CFE4159BD2D1Q46695930-2CE4EC62-6B09-450C-AF8B-96ED9E439DBDQ46905127-141A5C6E-70F1-4D6A-9729-11A7D3566D74Q47903407-98E270A7-E820-419A-A744-5801ACC30B94Q48050461-70AC1C2B-4F08-4DB0-8941-CBE0940BF47FQ48281038-BB5D36CC-A1E0-4C05-9C21-C8A6E226ECCCQ48898805-0D13FCB8-3063-4B05-81CC-64EC503950CCQ50220408-C3913234-A17D-49D1-AC3E-917994595D46Q50516134-E84BA4CC-A392-4193-87C9-29CAC77A6894
P2860
Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Direct fluorescence monitoring ...... halimide theragnostic prodrug.
@en
Direct fluorescence monitoring ...... halimide theragnostic prodrug.
@nl
type
label
Direct fluorescence monitoring ...... halimide theragnostic prodrug.
@en
Direct fluorescence monitoring ...... halimide theragnostic prodrug.
@nl
prefLabel
Direct fluorescence monitoring ...... halimide theragnostic prodrug.
@en
Direct fluorescence monitoring ...... halimide theragnostic prodrug.
@nl
P2093
P356
P1476
Direct fluorescence monitoring ...... halimide theragnostic prodrug.
@en
P2093
Chulhun Kang
Ji Hye Han
Jin Young Kim
Jonathan L Sessler
Jong Seung Kim
Min Hee Lee
Sankarprasad Bhuniya
P304
12668-12674
P356
10.1021/JA303998Y
P407
P577
2012-06-06T00:00:00Z